| Literature DB >> 26361388 |
M Shamim Hasan Zahid1, Sharda Prasad Awasthi1, Masahiro Asakura1, Shruti Chatterjee1, Atsushi Hinenoya1, Shah M Faruque2, Shinji Yamasaki1.
Abstract
Use of natural compounds as antivirulence drugs could be an alternative therapeutic approach to modify the outcome of bacterial infections, particularly in view of growing resistance to available antimicrobials. Here, we show that sub-bactericidal concentration of anethole, a component of sweet fennel seed, could suppress virulence potential in O1 El Tor biotype strains of toxigenic Vibrio cholerae, the causative agent of the ongoing 7th cholera pandemic. The expression of cholera toxin (CT) and toxin coregulated pilus (TCP), the major virulence factors of V. cholerae, is controlled through a regulatory cascade involving activation of ToxT with synergistic coupling interaction of ToxR/ToxS with TcpP/TcpH. We present evidence that anethole inhibits in vitro expression of CT and TCP in a toxT-dependent but toxR/toxS-independent manner and through repression of tcpP/tcpH, by using bead-ELISA, western blotting and quantitative real-time RT-PCR assays. The cyclic AMP (cAMP)-cAMP receptor protein (CRP) is a well-studied global signaling system in bacterial pathogens, and this complex is known to suppress expression of tcpP/tcpH in V. cholerae. We find that anethole influences the virulence regulatory cascade by over-expressing cyaA and crp genes. Moreover, suppression of toxigenic V. cholerae-mediated fluid accumulation in ligated ileum of rabbit by anethole demonstrates its potentiality as an antivirulence drug candidate against the diseases caused by toxigenic V. cholerae. Taken altogether, these results revealing a mechanism of virulence inhibition in V. cholerae by the natural compound anethole, may have relevance in designing antivirulence compounds, particularly against multiple antibiotic resistant bacterial pathogens.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26361388 PMCID: PMC4567338 DOI: 10.1371/journal.pone.0137529
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Bacterial strains and plasmids used in this study.
| Strains or plasmids | Relevant characteristics | Source or reference |
|---|---|---|
|
| ||
|
| O1 El Tor, | India, 1970 |
|
| O1 El Tor, | India, 1980 |
|
| O1 El Tor, | Peru, 1991 |
|
| O1 El Tor, | India, 1993 |
|
| O1 El Tor variant, | Bangladesh, 1993 |
|
| O1 El Tor variant, | India, 1994 |
|
| O1 El Tor variant, | India, 2000 |
|
| O1 El Tor variant, | India, 2000 |
|
| O1 El Tor variant, | India, 2000 |
|
| O1 El Tor variant, | Mozambique, 2004 |
|
| O139, | India, 1992 |
|
| O139, | India, 2000 |
|
| O1 classical, | India, 1948 |
|
| O1 classical, | India, 1964 |
|
| ||
| Δ | Derivative of El Tor variant strain CRC41 carrying deletion of | This study |
| gene encoding adenylate cyclase | ||
| Δ | Derivative of El Tor variant strain CRC41 carrying deletion of | This study |
| gene encoding cAMP receptor protein | ||
|
| ||
| DH5αλpir | supE44 DlacU169 (/80 lacZDM15) hsdR17 recA1 endA1 gyrA96 thi-1 | [ |
|
| ||
| SM10λpir |
| [ |
|
| ||
| pWM91 |
| [ |
| pΔ | pWM91::ΔVC0122, Ampr | This study |
| pΔ | pWM91::ΔVC2614, Ampr | This study |
| pCyaA | pBR322 carrying | This study |
| pCRP | pBR322 carrying | This study |
| pTcpA | pET-28a(+) carrying entire | This study |
| pTcpPH | pET-28a(+) carrying entire | This study |
a ctxB genotyping of the wild-type V. cholerae strains was determined as described in our previous study [17].
Sequences of oligonucleotides used in this study.
|
|
|
|
| |
|
| GGA GGG AAG AGC CGT GGA T |
|
| CAT CAT GCA CCG CCG GGT TG |
|
| CAT CGA TGA TCT TGG AGC ATT C |
|
| GGG ATA TGT TTC CAT TTA TCA ACG T |
|
| TGC TTT CGC TGC TGT CGC TGA TCT T |
|
| GCG ACA CTC GTT TCG AAA TCA |
|
| TGA TGA TCT TGA TGC TAT GGA GAA A |
|
| TAC GCG TAA TTG GCG TTG GGC AG |
|
| TCA TCC GAT TCG TTC TTA ATT CAC |
|
| GCT TTC GCG AGC CAT CTC T |
|
| CTT CAA CCG TTT CCA CTC GGG CG |
|
| CGA AAC GCG GTT ACC AAT TG |
|
| TGC CAT TAG GCA GAT ATT TCA CA |
|
| TGA CGT CTA CCC GAC TGA GTG GCC C |
|
| GCA ACC GCC CGG CTA T |
|
| TGG TAC ACC AAG CAT AAT ACA GAC TAA G |
|
| TAC TCT GTG AAT ATC ATC CTG CCC CCT GTC |
|
| AGG CCA AAG TGC TTT AAT TAT TTG A |
|
| GCC GTG ATT ACA ATG TGT TGA GTA T |
|
| TCA ACT CGG CAA AGG TTG TTT TCT CGC |
|
| TCA GCC GTT AGC AGC TTG TAA G |
|
| TCG ACC TCG AAG CGC TTA TT |
|
| CTG CGC TAT CAG GCG AAA CTA AAA CGA AA |
|
| GGT GCA CGT TTG CCT TTT G |
|
| CAC ACT GCT CAA CCC ACA AAT T |
|
| CCC CAG ACC TGC ATG AGC CCG |
|
| CCA GCA CAA ACC TCA ATA AAA CTT AA |
|
| GAT GCG CCT TTC AGG TCA A |
|
| TCG TCG TCT GCA AGT GAC CAG CCA |
|
| CGC AAG GTC GCC AAC TTT |
|
| GCG CAA TCT CGG CAA TAT CT |
|
| CAC CAC GAC CAA TGC CGC GTT TA |
|
| AAA TCG CGT TGG AAG TGT TTG |
|
| GCA GCA ACG TTT AGA GCG TTT |
|
| CGT CGT AAT TTA CTG GTT CGC CAA GCA |
|
| TCG TCC GCC CAT TGA ATC |
|
| GCA TGA GCG TAA TGC CTA AAC C |
|
| TCT GAA CAT GCG CTG CGA ACA ACA |
|
| TTC AAG CCA GCG CAC TGA |
|
| CGG GAA TCG CAC CAA AAG |
|
| CGC AGA ATG GCC GCA AAA CTA TCG |
|
| CGA CTC AAA TAC ACC AAA TTG CA |
|
| GCT ACC GGA CGT TCA TCC A |
|
| CGC TGA TGG TCG CCA AGC CTT TAT T |
|
| CAT TGA TTG CGG CAT CAG TTT |
|
|
|
|
| CAA TTT GGT AAA GGC TCC ATC AT |
|
| CTT AGG CGA CAA CCG CGC |
|
| CCG GTC GAA ATG GTT TCT ACA |
|
| |
|
| GACCGGAACATCTTTCATTG |
|
| GATCG |
|
| AGAGACG |
|
| GATCG |
|
| GACTGGC |
|
| TATACAGTGGCCCAGTTTGC |
|
| ATTCCATCGTCCGTTCAATG |
|
| GATCG |
|
| AGAGACG |
|
| GATCG |
|
| GACTGGC |
|
| CATTTTGAACATCCCGATCC |
|
| |
| TcpA-pr-F | GATCG |
| TcpA-pr-R | GATCG |
| TcpPH-pr-F | GATCG |
| TcpPH-pr-R | GATCG |
|
| |
| CyaA-PBR-comp F | GATCG |
| CyaA-PBR-comp R | GATCG |
| CRP-PBR-comp F | GATCG |
| CRP-PBR-comp R | GATCG |
aAll the primers and probes were designed using PRIMER EXPRESS software version 3.0 (Applied Biosystems Inc.).
bFAM was used as a 5'-reporter dye and TAMRA as a 3'-quencher dye to design each TaqMan probe.
cUnderlines below the nucleotide sequences indicate restriction enzyme cleavage sites. F, forward primer; P, probe; R, reverse primer; O, outer primer; I, inner primer.
Fig 1Effect of anethole on CT production in V. cholerae.
Anethole (50 μg/ml) drastically inhibited CT production in various serogroups and biotypes of V. cholerae. Open and close bars indicate CT production level as ng/ml without and with anethole, respectively. Numerical values in the x-axis represent the strain identity (see Table 1). ‘E’ and ‘C’ represent the presence of El Tor and classical type ctxB gene allele, respectively in the analyzed strains. Serogroups/biotypes of the V. cholerae strains are described below the respective ctxB allele. Values represent the averages ± SD of three independent experiments.
Fig 2Dose-dependent inhibitory effects of anethole on CT and TCP production in V. cholerae O1 El Tor variant strain CRC41.
(A) Effects of anethole on CT production and bacterial viability presented in the primary and secondary y-axis, respectively. x-axis indicates the concentrations of anethole used in these assays. Data are presented as the averages ± SD of three independent observations. By using two sample t-test, a single asterisk (*) represents p <0.05 and two asterisks (**) represents p <0.01 as compared with the anethole-free culture. (B) Dose-dependent effect of anethole on TcpA expression. Three independent experiments were conducted and a representative western blot image is shown here. The band signal intensities (shown below the image) of the image of western blot were quantified by ImageJ software (http://imagej.nih.gov/ij/), and normalized to that of without anethole sample (arbitrarily taken as 100%).
Fig 3A time-course effect of anethole on CT production in V. cholerae strain CRC41.
CT production was estimated from the CFS of initial stationary and followed by different length of shaking conditions, both in the presence (50 μg/ml) and absence of anethole. Open and close bars indicate CT production level as ng/ml without and with anethole, respectively. Results represented as the mean ± SD of three independent experiments.
Fig 4Dose-dependent effects of anethole on toxigenic V. cholerae (CRC41)-mediated fluid accumulation in ligated rabbit ileal loops (RILs).
This RIL image is a representative of three independent observations. Inoculum size, fluid accumulation (F/A) ratio, bacterial colonization and CT production of each loop are summarized in Table 3.
Effects of anethole on fluid accumulation, CT production and V. cholerae (CRC41) viability in rabbit ileal loops.
| Loop | Inoculum | Fluid accumulation ratio | Recovered bacteria | Total CT production |
|---|---|---|---|---|
| 1 | PBS | ND | <10 | Not det |
| 2 | 108 + 0.078 | 0.53 (± 0.09) | 1.8 (± 0.17)X109 | 180.7 (± 6.5) |
| 3 | 108 + 0.156 | 0.27 (± 0.03) | 1.3 (± 0.05)X109 | 35.7 (± 7.5) |
| 4 | 108 + 0.312 | 0.17 (± 0.02) | 2.9 (± 2.00)X108 | 9.3 (± 0.6) |
| 5 | 108 + 0.625 | 0.03 (± 0.03) | 1.4 (± 0.07)X108 | 2.7 (± 0.6) |
| 6 | 108 + 2.5 | ND | 1.1 (± 0.12)X108 | Not det |
| 7 | 108 + 10 | ND | 9.2 (± 2.90)X107 | Not det |
| 8 | 108 + 0 | 0.66 (± 0.11) | 2.6 (± 0.67)X109 | 330.3 (± 28) |
a*colony forming unit
**anethole
#(1% methanol)
bND, Not determined (significant amount of fluid was not accumulated)
c<10, no CFU was detected in 100 μl of PBS washing samples
dNot det, Not detected (significant amount of CT was not detected in fluids/washings). In all cases, values presented as the mean with ± SD of three independent rabbit experiments.
Fig 5Effect of anethole on the expression of virulence regulatory genes in V. cholerae strain CRC41.
qRT-PCR assay of the genes belonging to virulence regulatory cascade was performed with V. cholerae cells cultured (A) at 4 h of stationary and (B) followed by 2 h of shaking conditions, both in the presence (50 μg/ml) and absence (0.5% methanol) of anethole. ‘C’ indicates the control value of each target gene transcription, obtained from without anethole sample (arbitrarily taken as 1). Data are presented as the average ± SD of three independent experiments. By using two-sample t-test, a double asterisk (**) represents p <0.01 as compared with anethole untreated control. (C) Detection of TcpP by western blotting. Lanes ‘a’ and ‘b’ indicate TcpP (~26-kD) expression level in the presence (50 μg/ml) and absence (0.5% methanol) of anethole, respectively. Lane ‘c’ indicates the recombinant His6-T7-thrombin digestion site tagged TcpP (~31-kD), which was used as a positive control for detection of TcpP (See Methods section). In left panel (lanes a1 & b1), proteins were obtained from initial 4 h of stationary culture and right panel (lanes a2 & b2), proteins were from initial stationary followed by 2 h of shaking culture. This image is a representative of the three independent observations. The relative band signal intensities (shown below the image) of the image of western blot was quantified by ImageJ software, and normalized to that of without anethole sample (arbitrarily taken as 100%).
Fig 6Effect of anethole on the transcription of tcpPH regulatory genes in V. cholerae strain CRC41.
Relative transcription level of the tcpPH regulatory genes were examined both in the presence (50 μg/ml) and absence (0.5% methanol) of anethole, with V. cholerae cells cultured (A) at 4 h of stationary and (B) followed by 2 h of shaking conditions. ‘C’ indicates the control value of each target gene transcription, obtained from without anethole sample (arbitrarily taken as 1). Data are presented as the average ± SD of three independent experiments. By using two-sample t-test, a single asterisk (*) represents p <0.05 and a (**) represents p <0.01 as compared with anethole untreated control.
Fig 7The hypothetical regulatory cascade of CT production inhibition in V. cholerae by anethole.
In all cases, arrows indicate positive regulation while bars denote negative or inhibitory effects. Arrows besides the genes name represent significant increase and decrease of transcription of specific gene, in presence of anethole. Thick arrows represent the anethole-mediated effect on tcpPH suppression.